TY - JOUR
T1 - A reference standard for urinary tract infection research
T2 - a multidisciplinary Delphi consensus study
AU - Bilsen, Manu P.
AU - Conroy, Simon P.
AU - Schneeberger, Caroline
AU - Platteel, Tamara N.
AU - van Nieuwkoop, Cees
AU - Mody, Lona
AU - Caterino, Jeffrey M.
AU - Geerlings, Suzanne E.
AU - Köves, Bela
AU - Wagenlehner, Florian
AU - Kunneman, Marleen
AU - Visser, Leo G.
AU - Lambregts, Merel M.C.
AU - Hooton, Thomas
AU - Nicolle, Lindsay
AU - Trautner, Barbara
AU - Gupta, Kalpana
AU - Drekonja, Dimitri
AU - Huttner, Angela
AU - Schneidewind, Laila
AU - Johansen, Truls Erik Bjerklund
AU - Medina-Polo, José
AU - Kranz, Jennifer
AU - Ten Doesschate, Thijs
AU - Ott, Alewijn
AU - Kuil, Sacha
AU - Pulia, Michael
AU - Nwagwu, Veronica
AU - Carpenter, Christopher
AU - Russel, Andrew
AU - Stalenhoef, Janneke
AU - Clark, Sophie
AU - Southerland, Lauren
AU - Notermans, Daan
AU - Fure, Brynjar
AU - Baten, Evert
AU - Ninan, Sean
AU - Gerbrandy-Schreuders, Lara
AU - Van Halem, Karlijn
AU - Blanker, Marco
AU - Naber, Kurt
AU - Pilatz, Adrian
AU - Heytens, Stefan
AU - Vahedi, Ali
AU - Talan, David
AU - Kuijper, Ed
AU - Van Dissel, Jaap
AU - Cals, Jochen
AU - Dubbs, Sarah
AU - Veeratterapillay, Rajan
N1 - Publisher Copyright:
© 2024 Elsevier Ltd
PY - 2024/8
Y1 - 2024/8
N2 - The absence of a consensus-based reference standard for urinary tract infection (UTI) research adversely affects the internal and external validity of diagnostic and therapeutic studies. This omission hinders the accumulation of evidence for a disease that imposes a substantial burden on patients and society, particularly in an era of increasing antimicrobial resistance. We did a three-round Delphi study involving an international, multidisciplinary panel of UTI experts (n=46) and achieved a high degree of consensus (94%) on the final reference standard. New-onset dysuria, urinary frequency, and urinary urgency were considered major symptoms, and non-specific symptoms in older patients were not deemed indicative of UTI. The reference standard distinguishes between UTI with and without systemic involvement, abandoning the term complicated UTI. Moreover, different levels of pyuria were incorporated in the reference standard, encouraging quantification of pyuria in studies done in all health-care settings. The traditional bacteriuria threshold (105 colony-forming units per mL) was lowered to 104 colony-forming units per mL. This new reference standard can be used for UTI research across many patient populations and has the potential to increase homogeneity between studies.
AB - The absence of a consensus-based reference standard for urinary tract infection (UTI) research adversely affects the internal and external validity of diagnostic and therapeutic studies. This omission hinders the accumulation of evidence for a disease that imposes a substantial burden on patients and society, particularly in an era of increasing antimicrobial resistance. We did a three-round Delphi study involving an international, multidisciplinary panel of UTI experts (n=46) and achieved a high degree of consensus (94%) on the final reference standard. New-onset dysuria, urinary frequency, and urinary urgency were considered major symptoms, and non-specific symptoms in older patients were not deemed indicative of UTI. The reference standard distinguishes between UTI with and without systemic involvement, abandoning the term complicated UTI. Moreover, different levels of pyuria were incorporated in the reference standard, encouraging quantification of pyuria in studies done in all health-care settings. The traditional bacteriuria threshold (105 colony-forming units per mL) was lowered to 104 colony-forming units per mL. This new reference standard can be used for UTI research across many patient populations and has the potential to increase homogeneity between studies.
UR - http://www.scopus.com/inward/record.url?scp=85186952792&partnerID=8YFLogxK
U2 - 10.1016/S1473-3099(23)00778-8
DO - 10.1016/S1473-3099(23)00778-8
M3 - Review article
C2 - 38458204
AN - SCOPUS:85186952792
SN - 1473-3099
VL - 24
SP - e513-e521
JO - The Lancet Infectious Diseases
JF - The Lancet Infectious Diseases
IS - 8
M1 - doi.org/10.1016/S1473-3099(23)00778-8
ER -